What is Veracyte's common stock, par value (in dollars per share)?

Veracyte (VCYT) reported common stock, par value (in dollars per share) of $0 in Q1 2026.

How has Veracyte's common stock, par value (in dollars per share) changed year-over-year?

Veracyte's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.

What is the long-term trend for Veracyte's common stock, par value (in dollars per share)?

Over 5 years (2020 to 2025), Veracyte's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.

Veracyte VCYT Common stock, par value (in dollars per share)

Common stock, par value (in dollars per share) at other companies

Guardant HealthGH

——

Natera, Inc.NTRA

——

RevvityRVTY

——

Agilent TechnologiesA

——

Idexx LaboratoriesIDXX

——

DanaherDHR

——

Other financials

Income statement

See full

Revenue$139.1M+21.5%

Gross profit$101.2M+27.2%

Operating income$22.6M+680%

Net income$28.7M+307%

EPS (diluted)$0.35+289%

Balance sheet

See full

Cash & equivalents$264.8M+41.0%

Total debt$39.3M-22.1%

Total equity$1.3B+12.5%

Total assets$1.4B+9.2%

Cash flow

See full

Operating cash flow$35.2M+557%

CapEx$3.0M+62.8%

Free cash flow$32.3M+810%

Valuation

See full

Market cap$4.29B+10.7%

Profitability

See full

Gross margin70.9%+2.9pp

Operating margin14.3%+9.2pp

Net margin16.2%+9.1pp

FCF margin28.7%+11.7pp

Returns & leverage

See full

Return on equity6.9%+4.1pp

Debt / equity0×0.0×

Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's common stock, par value (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Veracyte's common stock, par value (in dollars per share)?: Veracyte (VCYT) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
How has Veracyte's common stock, par value (in dollars per share) changed year-over-year?: Veracyte's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
What is the long-term trend for Veracyte's common stock, par value (in dollars per share)?: Over 5 years (2020 to 2025), Veracyte's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.